Abbott LaboratoriesvsGSK

ABT and GSK stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$104.48

Value $182B

-0.22%
ABT's page

Abbott Laboratories (ABT) has a market value of $182B and GSK (GSK) $98.4B. Over the last year, with dividends, ABT moved -17.7% and GSK +5.9%. The P/E is 38.6 for ABT and 12.8 for GSK. Dividend yield: ABT 2.41%, GSK 3.65%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$182B

    GSK$98.4B

    ABT is 1.8 times GSK

  • Revenue, 12 months

    ABT$48.2B

    GSK$43.9B

    ABT is 1.1 times GSK

  • Net income, 12 months

    ABT$4.7B

    GSK$7.7B

    GSK is 1.6 times ABT

  • Operating margin

    ABT13.8%

    GSK24.3%

    10.5 points apart

  • ROIC

    ABT6.3%

    GSK18.6%

    12.3 points apart

  • P/E

    ABT38.6

    GSK12.8

    ABT is 3.0 times GSK

  • Dividend yield

    ABT2.4%

    GSK3.7%

    1.3 points apart

  • 5-year return

    ABT-10.3%

    GSK+41.2%

    51.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-10.3%

GSK+41.1%

10015020222023202420252026
Returns by period
PeriodABTWith dividendsGSKWith dividends
1 year since November 17, 2025-17.7%Price -19.6%+5.9%Price +2.2%
3 years since November 17, 2023+11.8%+3.8% a yearPrice +5.0%+55.0%+15.7% a yearPrice +38.0%
5 years since November 17, 2021-10.3%-2.1% a yearPrice -18.8%+41.2%+7.1% a yearPrice +14.2%
10 years since November 21, 2016+217.0%+12.2% a yearPrice +162.8%+100.8%+7.2% a yearPrice +26.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesGSKGSK

Valuation

ABTGSK
Valuation
Price$104.48$48.58
Market value$182B$98.4B
Enterprise value (EV)$208B$119B
P/E38.612.8
P/E, 5-year median33.713.1
P/B3.64.6
EV/EBIT31.411.1
Free cash flow yield3.7%8.7%

Results and growth

ABTGSK
Results and growth
Revenue, 12 months$48.2B$43.9B
Net income, 12 months$4.7B$7.7B
Free cash flow, 12 months$6.8B$8.6B
Earnings per share, 12 months$2.69$3.73
Revenue growth, year on year5.7%4.1%
Revenue growth a year, past+5.1%over 5 years+6.1%over 5 years
EPS growth a year, past+8.3%over 5 years-0.5%over 5 years

Margins and returns on capital

ABTGSK
Margins and returns on capital
Gross margin56.9%72.4%
Operating margin13.8%24.3%
Net margin9.8%17.5%
ROIC6.3%18.6%
ROE9.1%35.8%

Balance sheet

ABTGSK
Balance sheet
Cash$4.3B$4.6B
Total debt$31.2B$24.9B
Net debt / EBITDA3.31.5
Interest cover6.7×–

Dividends and buybacks

ABTGSK
Dividends and buybacks
Dividend yield2.4%3.7%
Dividend per share, 12 months$2.52$1.78
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%1.9%
Shareholder yield2.9%5.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or GSK

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or GSK?

By market value, Abbott Laboratories ($182B) is about 1.8 times GSK ($98.4B), at today's prices.

How did ABT and GSK stock do over the last 10 years?

Since November 21, 2016, ABT's price moved +162.8% and GSK's +26.4%. With dividends: ABT +217.0% (+12.2% a year), GSK +100.8% (+7.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or GSK?

The dividend yield at today's price is 2.41% for Abbott Laboratories and 3.65% for GSK. Over the last twelve months they paid $2.52 and $1.78 per share.

What is the P/E of ABT and GSK?

At today's price, the P/E is 38.6 for ABT and 12.8 for GSK. The median of the last five years was 33.7 and 13.1, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or GSK?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 17.5% for GSK, and the operating margin 13.8% and 24.3%. Revenue was $48.2B and $43.9B.

Which is the better investment, Abbott Laboratories or GSK?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.